EHA 2022 | BPDCN: unmet needs and challenges

Name: BPDCN: unmet needs and challenges
Uploaded: 2022-06-21T00:00:00Z
Duration: 57 s
Description: Uwe Platzbecker, MD, University of Leipzig, Leipzig, Germany, shares some insights into unmet needs in blastic plasmacytoid dendritic cell neoplasm (BPDCN), drawing focus on the importance of maintaining remission with novel treatment approaches. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Uwe Platzbecker • 21 Jun 2022

EHA 2022

Blastic Plasmacytoid Dendritic Cell Neoplasm Rare Diseases Tagraxofusp

Uwe Platzbecker, MD, University of Leipzig, Leipzig, Germany, shares some insights into unmet needs in blastic plasmacytoid dendritic cell neoplasm (BPDCN), drawing focus on the importance of maintaining remission with novel treatment approaches. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Disclosures

Receiving grant support, paid to GWT-TUD, from Amgen, lecture fees, grant support, paid to the University of Leipzig, fees for serving on a steering committee, consulting fees, and travel support from Celgene, grant support, paid to GWT-TUD, from Janssen Biotech, grant support, paid to University Dresden, from Merck and Novartis, and lecture fees from Novartis.